Importance Diagnosis of mental disorder is prevalent among people who have been
incarcerated. Nevertheless, community mental health services are often limited following release …

Background A high proportion of people receiving both oral and injectable opioid agonist
treatment report concurrent use of stimulants (ie cocaine and or amphetamines), which has …

Background To test whether there are gender differences in treatment outcomes among
patients receiving injectable opioids for the treatment of long-term opioid-dependence. The …

Background Substance use disorder (SUD) has become increasingly prevalent worldwide,
this study investigated the associations of SUD and alcohol, cannabis, opioid, or stimulant …

Background In a double-blind, non-inferiority randomized controlled trial injectable
hydromorphone, a licensed short acting opioid analgesic, was shown to be as effective as …

Background: One-third of Canadians meet the criteria for a mental or substance use disorder
at some point in their lifetime. While prevention and treatment efforts have been focused on …

Background Stimulant use has been rising among people with opioid use disorder in recent
years in North America, alongside a parallel rise in illicit drug toxicity (overdose) deaths. …

Introduction British Columbia (BC) declared an overdose public health emergency in 2016.
Since then, BC has consistently reported the highest overdose death rates of any province in …

Introduction The COVID-19 pandemic was preceded by an ongoing overdose crisis and
linked to escalating drug overdose deaths in British Columbia (BC). At the outset of these dual …

Objective To determine the effect of opioid and stimulant Risk Mitigation Guidance (RMG)
dispensations on mortality and acute care visits during the dual public health emergencies of …